August 20, 2025Obstetric Anesthesia Digest

Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes

View Full Paper

Ask AI

Bookmark

Adverse pregnancy outcomes are likely linked to the presence of novel antiphospholipid antibodies, which requires attention.
Evidence indicates that lupus anticoagulant is significantly predictive of pregnancy complications, emphasizing its importance.
The study involves assessing the relationship between antibodies such as aD1, aPS/PT, and lupus anticoagulant in an at-risk population.
The findings may highlight the need for targeted assessments regarding adverse pregnancy outcomes due to these antibodies.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis shows a connection between antiphospholipid antibodies, including aD1 and aPS/PT, and adverse pregnancy outcomes, indicating clinical relevance.

Cite This Study

Moyle et al. (2025) studied this question.

synapsesocial.com/papers/68af3e49cf1dd9ea359eb4a3 https://doi.org/10.1097/01.aoa.0001125544.61154.10

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis shows a connection between antiphospholipid antibodies, including aD1 and aPS/PT, and adverse pregnancy outcomes, indicating clinical relevance.

Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes

Key Points

Discussion

Implication

Cite This Study

Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes

Key Points

Discussion

Implication

Cite This Study

Keep reading

Keep reading